MAPT and Alzheimer disease: The large area and satisfactory electrical conductivity of the VG@Au improved the sensitivity of the sensor, achieving a lower LOD (0.1 pg/mL) than the tau concentration of healthy population (~15.6 pg/mL) and mild AD patients (~53.9 pg/mL) in plasma [62].